Cite
IL-37 improves mice myocardial infarction via inhibiting YAP-NLRP3 signaling mediated macrophage programming.
MLA
Wang, Yi-ming, et al. “IL-37 Improves Mice Myocardial Infarction via Inhibiting YAP-NLRP3 Signaling Mediated Macrophage Programming.” European Journal of Pharmacology, vol. 934, Nov. 2022, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.ejphar.2022.175293.
APA
Wang, Y., Zhang, J., Wu, B., Cao, X., Li, H., Chen, T., Huang, Y., Shen, X., Li, J., You, Y., & Shi, H. (2022). IL-37 improves mice myocardial infarction via inhibiting YAP-NLRP3 signaling mediated macrophage programming. European Journal of Pharmacology, 934, N.PAG. https://doi.org/10.1016/j.ejphar.2022.175293
Chicago
Wang, Yi-ming, Jin-jin Zhang, Bang-wei Wu, Xin-yue Cao, Hui Li, Tong-qing Chen, Yu-ran Huang, et al. 2022. “IL-37 Improves Mice Myocardial Infarction via Inhibiting YAP-NLRP3 Signaling Mediated Macrophage Programming.” European Journal of Pharmacology 934 (November): N.PAG. doi:10.1016/j.ejphar.2022.175293.